782487-28-9

Basic information

• Product Name: semaglutide
• Synonyms: semaglutide;AQX10;Rosiptor
• CAS NO: 782487-28-9
• Molecular Formula: C20H35NO2
• Molecular Weight: 321.4974
• Mol File: 782487-28-9.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 451.6±45.0 °C(Predicted)
• Appearance: /
• Density: 1.07±0.1 g/cm3(Predicted)
• PKA: 15.05±0.10(Predicted)
• CAS DataBase Reference: semaglutide(CAS DataBase Reference)
• NIST Chemistry Reference: semaglutide(782487-28-9)
• EPA Substance Registry System: semaglutide(782487-28-9)

Safety Data

• Hazardous Substances Data: 782487-28-9(Hazardous Substances Data)

Usage

Description

Semaglutide is a medication that belongs to the class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It is a synthetic peptide that mimics the action of the incretin hormone GLP-1, which is naturally produced in the gastrointestinal tract. Semaglutide possesses the ability to stimulate insulin release from the pancreas, decrease glucose production in the liver, slow gastric emptying, and reduce appetite, making it a promising pharmaceutical candidate for managing type 2 diabetes and improving cardiovascular outcomes.

Uses

Used in Pharmaceutical Industry:
Semaglutide is used as an antidiabetic agent for managing type 2 diabetes. It helps control blood sugar levels by stimulating insulin release from the pancreas and decreasing the amount of glucose produced by the liver. Additionally, it slows down the emptying of the stomach and reduces appetite, leading to weight loss.
Semaglutide is used as a cardiovascular outcome improver for patients with type 2 diabetes. It has been shown to improve cardiovascular outcomes in these patients, reducing the risk of major adverse cardiovascular events.
Although semaglutide has potential side effects such as gastrointestinal issues and pancreatitis, it has been found to be an effective and safe option for managing type 2 diabetes when used appropriately.